What should I know first?

Catatonia is a pattern of changes in movement, speech and behaviour, not simply a severe form of schizophrenia. Someone may become unusually still and difficult to engage, remain in a posture or repeat movements or words. Others become intensely restless or alternate between reduced and excessive activity.

A person who cannot respond may still be aware of what is happening around them. Catatonia can occur with several psychiatric or medical conditions. This article is a syndrome overview: it does not combine all associated, medical and substance-related diagnoses into one supposedly identical disorder.

How Common Is It?

Catatonia is probably underrecognised, and frequency depends strongly on where and how it is assessed. The Royal College of Psychiatrists describes it in roughly one in ten psychiatric inpatients, which is not a general-population prevalence estimate. Rates in medical wards, specialist services and developmental populations cannot be assumed to be the same.

Quiet, withdrawn presentations can be overlooked if staff expect only dramatic immobility. Awareness of the syndrome is important because recognition can change treatment, but a population statistic cannot determine whether an individual’s symptoms are catatonia.

Assessment in the United Kingdom

A psychiatric and physical assessment considers movement, speech, recent change and underlying illness. The Royal College describes clinical observation, examination and selected blood tests, scans or EEG. A monitored lorazepam challenge can support assessment; it is not a home test.

UK terminology and care context

Catatonia is not synonymous with schizophrenia. UK patient information recognises psychiatric, neurological, metabolic, infectious and substance-related causes. An existing psychiatric diagnosis must not prevent investigation of a new physical illness.

Signs and Symptoms

Signs can include markedly reduced movement, little or no speech, prolonged postures, repetitive actions or copying another person’s words or movements. Some people resist movement or appear unable to begin an action. Others show agitation that is not easily explained by their surroundings.

These findings are assessed as a pattern, not diagnosed from one unusual gesture. Eating, drinking and communication may become difficult. Severe immobility can lead to medical complications, while fever, rigidity, unstable vital signs or rapid deterioration are warning signs of a potentially life-threatening presentation.

What Causes It?

Catatonia may accompany depression, bipolar disorder, schizophrenia and other conditions. It can also occur with neurological illness, infection, metabolic problems, medication effects or substance withdrawal. Finding a familiar psychiatric diagnosis should not stop a medical assessment. Autistic people can develop catatonia, but longstanding communication or movement differences are not themselves evidence of it: a meaningful change from baseline is especially important.

The precise reason it develops in one person remains uncertain. Treatment therefore needs to address the syndrome and investigate its underlying context, rather than assume one universal cause.

What Do We Know About the Brain?

Research examines how brain systems coordinate movement, emotional responses and voluntary action. Several possible processes may lead to a similar outward pattern, which is one reason catatonia can accompany different illnesses. Current knowledge does not provide a single diagnostic scan or laboratory test.

A response to treatment may be clinically informative without proving one simple explanation of brain function. Describing these limits helps avoid the mistaken idea that reduced movement always reflects either deliberate behaviour or one particular psychiatric disease.

Conditions With Similar Symptoms

Delirium, seizures without obvious convulsions, neurological movement disorders and severe medication reactions can resemble parts of catatonia. These conditions may also coexist, so the task is not always to choose only one label. Neuroleptic malignant syndrome, a serious reaction associated with certain medicines, is an important urgent differential when fever and rigidity occur.

Depression-related slowing, longstanding autistic traits and ordinary unwillingness to speak are not automatically catatonia. A careful physical and neurological assessment is essential, particularly when someone deteriorates rapidly or cannot provide a clear history.

Other Conditions That Can Occur Together

The associated illness and the complications of reduced movement may both need active care. Dehydration, malnutrition, pressure injuries, infection and blood clots are among the concerns in a person who is immobile or unable to eat and drink adequately. These are preventable or treatable medical problems, not merely secondary inconveniences.

Anxiety or fear may be intense even when the person appears unresponsive. Supporters can help by describing baseline functioning and recent changes. The treatment team should also attend to communication needs and the person’s dignity throughout care.

What to Expect Over Time

Many people improve with treatment, sometimes quickly, but speed and completeness of recovery vary with the cause and duration. Persistent symptoms or recurrence require reassessment rather than a conclusion that the person is choosing not to recover. Improvement in movement does not necessarily mean the underlying illness or physical complications have resolved.

Follow-up should address those problems and review medication needs. People may also want help making sense of a frightening episode. A plan for recognising early changes can be useful, especially if catatonia has occurred before.

Everyday Life and Support

Speak respectfully and explain what you are doing, even when a person cannot answer. Familiar, calm support can reduce fear, and accounts from relatives or caregivers may be valuable with appropriate safeguards. Do not force food, drink or medicine into someone who cannot swallow safely; seek clinical help.

Avoid interpreting immobility or silence as laziness or defiance. After recovery, ask what the person remembers and what support they would prefer in any future episode. New marked reduction in movement or speech, inability to drink, fever or rapidly changing physical status warrants urgent assessment.

Treatment and support in the United Kingdom

Hospital care is often needed when eating, drinking or movement are severely affected. Treatment addresses the cause and physical complications. Specialist options include lorazepam and, particularly for severe illness or inadequate response, electroconvulsive therapy under general anaesthesia.

Can medication help?

Lorazepam requires medical supervision and monitoring. It may need gradual withdrawal after recovery; stopping suddenly is unsafe. A medication plan for one episode should not be treated as a standing instruction for another.

History

Karl Kahlbaum described catatonia in the nineteenth century as a pattern that could cross diagnostic boundaries. Later classifications linked it strongly with schizophrenia, and older records may refer to catatonic schizophrenia. That historical association was too narrow. Modern classifications recognise catatonia in mood disorders, other psychiatric conditions and medical or substance-related presentations.

DSM-5 removed the old schizophrenia subtype and made the broader use of catatonia clearer. ICD-11 gives catatonia its own grouping while also distinguishing secondary medical presentations. This change matters clinically: a person who becomes immobile or stops speaking should not automatically be assumed to have schizophrenia.

Current care combines recognition of the syndrome with urgent attention to physical complications and investigation of its cause.

Sources and References

  1. Evidence-based consensus guidelines for the management of catatonia (2023)

    Scope: International scientific/background source; no UK prescribing or service applicability inferred.

  2. Catatonia

    Scope: United Kingdom.

  3. Catatonia: information for patients and carers

    Scope: International scientific/background source; no UK prescribing or service applicability inferred.

  4. Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (2024)

    Scope: International scientific/background source; no UK prescribing or service applicability inferred.

  5. Delirium

    Scope: International scientific/background source; no UK prescribing or service applicability inferred.

  6. Highlights of Changes from DSM-IV-TR to DSM-5 (2013)

    Scope: International scientific/background source; no UK prescribing or service applicability inferred.

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top